Add thelocalreport.in As A Trusted Source
The Trump administration is moving forward with plans to reclassify marijuana under Schedule III of the Controlled Substances Act, a move that would reduce barriers to medical research into applications of cannabis and CBD products but leave federal restrictions in place. recreational drug use,
chairman donald trump The move was announced during a Thursday Oval Office signing ceremony with cannabis industry representatives and Health and Human Services officials.
He said, “This action is requested by American patients suffering from extreme pain, terminal diseases, aggressive cancers, seizure disorders, neurological problems and others, including many veterans with service-related injuries and older Americans who struggle with chronic medical problems and have their quality of life seriously impaired.”
Trump said he has received more phone calls to reschedule cannabis than any other issue and suggested the issue has the support of 82 percent of Americans. But he also stressed that action Does not legalize marijuana For recreational use under federal law.
He said, “It does not in any way ban its use as a recreational drug – it has nothing to do with that.”
“It is never safe to use powerful controlled substances recreationally, and especially in this case,” he said. “So unless a medication is recommended by a doctor for medical reasons, don’t do it.”
Trump’s order directs the attorney general to expedite rescheduling marijuana to Schedule III under the Controlled Substances Act, a senior administration official told reporters.
“The President is very focused on the potential medical benefits, and he has directed a common-sense approach that will automatically begin working to improve medical marijuana and CBD research to better inform patients and doctors. That’s the primary goal,” he said.
The official also said the White House deputy chief of staff for legislative affairs will be directed to ensure that Congress passes legislation to provide Americans “access to appropriate full spectrum CBD products, while still restricting the sale and access of products that are serious and dangerous.” potentially life-threatening health risks,
Trump intended to “remove barriers to research,” the official said.
She added, “The President has heard from a lot of people who have talked about the potential benefits of medical marijuana and CBD, but he’s also heard from patients and doctors that there isn’t enough research to inform medical guidelines, that many patients are using these products without talking to their doctor.”
The official also said Trump is “very focused” on ensuring that “people who are using medical marijuana, especially in their state regulated programs, have better research that can inform both them and their doctors.”
A second official told reporters that Trump’s order was part of his effort to “fulfill his promises to improve health care for all Americans” and said the president sees rescheduling marijuana as “a common sense action that will let us better study and understand the possibilities of medical marijuana and CBD for patients, but also better understand the risks.”